Eli Lilly's stock (NYSE: LLY ) has been duly adjusted this AM following a surprise slash to its full year 2024 guidance. This marks a stark pivot from two consecutive quarters of raised revenue guidance in the billions, driven by continued demand momentum Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not ...